Healthcare provider profile · identity verified

Victor A Ferzoco, MD

Internal Medicine · HYDE PARK, MA · NPI 1396730396

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	454	130
Oxycodone Hcl	Oxycodone Hcl	300	31
Losartan Potassium	Losartan Potassium	270	70
Amlodipine Besylate	Amlodipine Besylate	251	68
Lisinopril	Lisinopril	221	66
Gabapentin	Gabapentin	183	44
Metoprolol Succinate	Metoprolol Succinate	169	46
Albuterol Sulfate Hfa	Albuterol Sulfate	163	55
Rosuvastatin Calcium	Rosuvastatin Calcium	159	48
Levothyroxine Sodium	Levothyroxine Sodium	155	40
Omeprazole	Omeprazole	133	37
Famotidine	Famotidine	118	36
Metformin Hcl	Metformin Hcl	110	27
Ibuprofen	Ibuprofen	98	23
Lorazepam	Lorazepam	94	20
Sertraline Hcl	Sertraline Hcl	93	25
Trazodone Hcl	Trazodone Hcl	93	28
Metformin Hcl Er	Metformin Hcl	89	26
Simvastatin	Simvastatin	83	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	77	14
Furosemide	Furosemide	74	19
Eliquis	Apixaban	73	22
Hydrochlorothiazide	Hydrochlorothiazide	71	21
Duloxetine Hcl	Duloxetine Hcl	68	13
Tizanidine Hcl	Tizanidine Hcl	68	14
Tamsulosin Hcl	Tamsulosin Hcl	67	18
Jardiance	Empagliflozin	66	17
Carvedilol	Carvedilol	64	15
Pantoprazole Sodium	Pantoprazole Sodium	64	15
Pregabalin	Pregabalin	60	13
Ozempic	Semaglutide	57	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	13
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	56	suppressed
Chlorthalidone	Chlorthalidone	53	16
Tramadol Hcl	Tramadol Hcl	53	suppressed
Fluticasone Propionate	Fluticasone Propionate	52	20
Clonazepam	Clonazepam	49	suppressed
Atenolol	Atenolol	46	13
Oxycontin	Oxycodone Hcl	45	suppressed
Ezetimibe	Ezetimibe	44	13
Trulicity	Dulaglutide	44	suppressed
Pravastatin Sodium	Pravastatin Sodium	43	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Glipizide Er	Glipizide	41	suppressed
Diclofenac Sodium	Diclofenac Sodium	40	15
Valacyclovir	Valacyclovir Hcl	40	14
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	39	suppressed
Ventolin Hfa	Albuterol Sulfate	39	11
Prednisone	Prednisone	37	15
Topiramate	Topiramate	37	suppressed
Varenicline Tartrate	Varenicline Tartrate	36	16
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	suppressed
Potassium Chloride	Potassium Chloride	35	11
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	33	16
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Ondansetron Odt	Ondansetron	28	suppressed
Rizatriptan	Rizatriptan Benzoate	28	suppressed
Alprazolam	Alprazolam	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	11
Xarelto	Rivaroxaban	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Testosterone	Testosterone	26	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Finasteride	Finasteride	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Allopurinol	Allopurinol	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Linzess	Linaclotide	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Torsemide	Torsemide	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Valsartan	Valsartan	15	suppressed
Diazepam	Diazepam	14	suppressed
Epinephrine	Epinephrine	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Nystatin	Nystatin	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Repatha Syringe	Evolocumab	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Nystop	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error